ACH
BIO icon

ArrowMark Colorado Holdings’s Bio-Rad Laboratories Class A BIO Stock Holding History

ArrowMark Colorado Holdings’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-9
Closed -$1K – 316
2016
Q3 		$1K Buy
+9
New +$1.37K ﹤0.01% 436

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

ArrowMark Colorado Holdings's BIO Position: Q4 2016 in Review

ArrowMark Colorado Holdings sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2016, closing a stake of 9 shares — an estimated $1K sold.

ArrowMark Colorado Holdings first reported a position in BIO in Q3 2016 and held it in 1 quarter. The position peaked at $1K in Q3 2016. 261 funds tracked by Wall St. Rank hold BIO as of Q4 2016.

  • ArrowMark Colorado Holdings reported no remaining Bio-Rad Laboratories Class A position as of Q4 2016 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 9 Bio-Rad Laboratories Class A shares in Q4 2016, an estimated $1K.
  • ArrowMark Colorado Holdings first reported a position in Bio-Rad Laboratories Class A in Q3 2016 and held it in 1 quarter.
  • ArrowMark Colorado Holdings's Bio-Rad Laboratories Class A position peaked at $1K in Q3 2016.
  • 261 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2016.

Based on ArrowMark Colorado Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.